OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing AS1411 for constructing ANM-PROTACs
Xuekun Fu, Jin Li, Xinxin Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1290-1304.e7
Closed Access | Times Cited: 6
Xuekun Fu, Jin Li, Xinxin Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1290-1304.e7
Closed Access | Times Cited: 6
Showing 6 citing articles:
A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer
Xue Zheng, Ying Wang, Huaiyu Duan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Xue Zheng, Ying Wang, Huaiyu Duan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Design of Mdm2 Protac Degraders with a Built-In Tumor-Targeting Ability
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
(2024)
Closed Access
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
(2024)
Closed Access
Protocol for constructing tumor-targeting ANM-PROTACs for degradation of transcription factors
Jin Li, Chao Liang
STAR Protocols (2024) Vol. 5, Iss. 3, pp. 103220-103220
Open Access
Jin Li, Chao Liang
STAR Protocols (2024) Vol. 5, Iss. 3, pp. 103220-103220
Open Access
Design of a Membrane-Anchored DNAzyme-Based Molecular Machine for Enhanced Cancer Therapy by Customized Cascade Regulation
Man‐Sha Wu, Ze‐Rui Zhou, Xiaoyuan Wang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 9, pp. 2869-2877
Open Access
Man‐Sha Wu, Ze‐Rui Zhou, Xiaoyuan Wang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 9, pp. 2869-2877
Open Access
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18865-18882
Closed Access
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18865-18882
Closed Access
Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor- and vascular endothelial cells
Ziting Feng, Duoli Xie, Fang Qiu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117027-117027
Closed Access
Ziting Feng, Duoli Xie, Fang Qiu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117027-117027
Closed Access
Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access
